2-(morpholin-4-yl)ethyl 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylate
| Title | Journal |
|---|---|
| Italian guidelines for primary headaches: 2012 revised version. | The journal of headache and pain 20120501 |
| Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. | PloS one 20120101 |
| Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | Healthcare informatics research 20101201 |
| Effects of perioperative intravenous low dose of ketamine on postoperative analgesia in children. | European journal of anaesthesiology 20100101 |
| Drug use in children: cohort study in three European countries. | BMJ (Clinical research ed.) 20080101 |
| Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes. | The Journal of physiology 20030515 |
| Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. | Rheumatology (Oxford, England) 20011101 |
| Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. | Immunopharmacology and immunotoxicology 20011101 |
| Modulation of arachidonic acid metabolism by orally administered morniflumate in man. | Agents and actions 19910701 |
| [A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis]. | Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques 19910101 |
| A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate). | Agents and actions 19840201 |